Novartis eyes buy-out of biopharma firm Speedel
Thursday July 10, 2008, 5:49 pmZURICH (AFP) - Swiss pharmaceutical giant Novartis said Thursday it had boosted its stake in biopharmaceutical firm Speedel by 51.7 percent and aimed to buy it out completely for 907 million Swiss francs (560 millions euros, 882 million dollars).
Novartis added the 51.7 percent to its existing 9.7 stake in Speedel for 130 Swiss francs cash per share, it said in a statement.
The 882 million dollar figure is what Novartis expects to pay for the entire acquisition of Speedel, excluding its initial 9.7 percent stake.
... read original articleThu 10th July 2008 - 05:49pm
Previous Article: Gas shortage to cut Alumina A $31 mln in Q3 earnings
Next Article: German railway boss insists share listing does not threaten service
Next Article: German railway boss insists share listing does not threaten service
Latest news:
- Fuel stalemate in Greece as truckers refuse to end strike
- Fuel stalemate in Greece as truckers refuse to end strike
- China invests -amp 3640 bln in Iran oil- gas- minister
- Unflued heaters put school maintenance funds at risk
- Beef industry wants tougher laws on meat labelling
- House energy star ratings unreliable
- Union warns of train danger after near miss
- Parental leave levy wont push up prices- Coles
- Parental leave levy wont push up prices- Coles
- US economic growth slows to sluggish pace
Last 7 days news:
- Todays News (31)
- 30th July 2010 (127)
- 29th July 2010 (126)
- 28th July 2010 (139)
- 27th July 2010 (143)
- 26th July 2010 (116)
- 25th July 2010 (32)
